12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

Hawaii Bio, Merck & Co Inc. deal

Hawaii Biotech reacquired a patent family to West Nile virus vaccine technology and non-exclusive rights to a recombinant protein expression technology from Merck. Hawaii Biotech will...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >